APG-808 is under clinical development by Apogee Therapeutics and currently in Phase I for Unspecified Immunological Disorders.

Pegtarazimod is under clinical development by ReAlta Life Sciences and currently in Phase I for Coronavirus Disease 2019 (COVID-19) Associated Acute Lung Injury.

Regeneron Pharmaceuticals is a strong investment with robust growth potential, fueled by FDA approvals and resilient market ...

The spread of HMPV in China has caused scare among people worldwide. Social media shows pictures of overwhelming number of patients in China. As the virus is being compared with the Covid-19, let us ...

China is reportedly witnessing a surge in human metapneumovirus (HMPV) cases, sparking concerns of another health crisis ...

HMPV is mainly transmitted through droplets or aerosols produced by coughing and sneezing. The Chinese CDC states that close ...

China is reportedly at the centre of a new virus just five years after the outbreak of Covid-19. The human metapneumovirus ...

Multiple viruses, including influenza A, HMPV, Mycoplasma pneumoniae, and Covid-19 are reportedly circulating in China ...

China approves GSK's Nucala for chronic rhinosinusitis with nasal polyps, adding to its existing uses in asthma and other ...

China is currently facing a surge in Covid-like human metapneumovirus (hMPV) cases, raising concerns across the country. Know ...

The surge in infections is being examined, especially since it coincides with the winter season, a time when respiratory ...

China is witnessing a surge in respiratory illnesses, including HMPV, influenza, and Covid-19, predominantly affecting ...